Cancer is the second leading cause of death globally behind cardiovascular disease. The cancer burden continues to grow globally, exerting tremendous physical, emotional and financial strain on individuals, families, communities and health systems. Developing new and effective therapeutic approaches in this complex setting remains a challenge.
Our oncology team of scientists provides top-tier pharmacology services spanning from preclinical and translational science to clinical development. With extensive industry experience across various drug targets and modalities, we are skilled in establishing and executing innovative mechanistic cellular and in vivo assays. Leveraging our broad range of models, we delve deeply into the biology of drug development programs to uncover the molecular drivers of efficacy. Our team collaborates closely with you to design, support and deliver customised pharmacology studies that align with your specific objectives.
Find out how we can support your with our in vivo oncology models.
learn more
We offer a variety of immune-oncology models for your discovery efforts.
learn more
Explore our target discovery capabilities supporting your drug discovery and development projects.
learn more
Contact Us
Search